BioNTech doses first patient in herpes vaccine candidate clinical trialR&D, TherapeuticsThis effort is the first result of the research collaboration established in 2018 between the University of Pennsylvania and BioNTech aimed at developing novel mRNA vaccine candidates for the prevention and treatment of various infectious diseases. Read more December 21, 2022/by Reuters Health https://www.pharmalive.com/wp-content/uploads/2021/04/BioNTech-expects-vaccine-trial-results-for-babies-by-September-Reuters-4-29-21.jpg 503 960 Reuters Health https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png Reuters Health2022-12-21 10:01:452022-12-21 10:08:16BioNTech doses first patient in herpes vaccine candidate clinical trial